Brief: ODI Pharma Says Group's Net Sales For Q3 Amounted To SEK 0 (SEK 1,567)
27/05/2021 17:28
May 27 (Reuters) - Odi Pharma AB (publ) ODI.TE :
* GROUP'S NET SALES FOR Q3 AMOUNTED TO SEK 0 (SEK 1,567)
* GROUP'S Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK
-41,280
(SEK -1,662,333)
* QTRLY RESULT PER SHARE AMOUNTED TO SEK -0.0031 (SEK
-0.11).
Source text for Eikon: ID:nWkr9nCGD3
Further company coverage: ODI.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odi Pharma AB (publ)
See all newsBrief: Odi Pharma Proposes Directed Share Issue Of Approximately Sek 2.0 Million
Brief: ODI Pharma Reports Revised Qtrly Result Per Share Amounted To SEK -0.09 (-0.05)
Brief: ODI Pharma Says Group's Net Sales For Q2 Amounted To Sek 458,620
Brief: ODI Pharma Says Group's Net Sales For Q3 Amounted To SEK 0 (SEK 1,567)
Brief: ODI Pharma Q2 Loss After Financial Items Narrows To SEK 0.8 Mln